Please complete at least one question.
Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, New Brunswick, USA
Dr Kaufman presents results at AACR 2017 of a trial administering avelumab to patients with advanced Merkel cell carcinoma who had not responded to chemotherapy.
Slides from this presentation are available here, and you can read more about the results here.
Dr Kaufman spoke with ecancer about these results here.